Texas A&M Researchers Identified Cancer Cell Pathway

A study revealed that the URM1 cellular pathway helps cancer cells survive oxidative stress.

Updated on Sept. 23, 2026 in Cancer

Glass laboratory vials and a micropipette on a clean steel bench near a molecular protein model in a research lab. — Texas A&M researchers discovered that the URM1 cellular pathway enables cancer cells to survive stress, suggesting new avenues for combining drugs like pevonedistat. AI Illustration. Upload story photo >

Live Poll

Do you believe recent discoveries in cellular pathways will lead to more effective cancer treatments?

Texas A&M researchers identified the URM1 cellular pathway as a key mechanism that allows cancer cells to survive oxidative stress. The findings also suggest that combining drugs like pevonedistat with cisplatin may effectively increase cancer cell death.

Why it matters

The URM1 pathway helps cancer cells withstand molecular damage caused by metabolism and treatments, making it a critical focus for new therapies. Disrupting this survival mechanism could improve the efficacy of existing cancer treatments for patients.

Researchers identified two enzymes, NAE1/UBA3 and UBE2M, as critical drivers of the URM1 modification process in human cells. Studies showed that high URM1 expression levels correlate with poorer clinical outcomes for patients with liver cancer.

The players

Texas A&M University

This public research university is home to a major medical and scientific research community in the United States.

Nature Communications

This is an open-access, peer-reviewed journal that publishes high-quality research from all areas of the natural sciences.

The details

The team at Texas A&M University developed a specialized molecular probe to observe protein activity after disrupting the NAE1/UBA3 and UBE2M enzymes. By inhibiting these enzymes with pevonedistat, researchers successfully killed liver cancer cells more effectively than when using treatments individually.

September 23, 2026: The research findings were published in the journal Nature Communications.

Deeper Dive

This study aligns with the NCI-supported Cancer Moonshot research initiatives, which aim to accelerate our understanding of cellular mechanisms to improve cancer treatment outcomes. By mapping the URM1 pathway, researchers are bridging a significant gap in our knowledge of how cancer cells adapt to oxidative stress.

This discovery offers a potential new strategy for enhancing the effectiveness of standard chemotherapy treatments like cisplatin. While the research is currently at the laboratory stage, it paves the way for future combination therapies that could lead to improved outcomes for liver cancer patients.

The takeaway

Understanding how cancer cells overcome oxidative stress provides a roadmap for developing drugs that weaken tumors against existing treatments. Future clinical studies will determine if targeting this pathway can be translated into safe and effective care for humans.